Konica Minolta to Join Global Oncogenic Gene Panel Research

The research collaboration combines the knowledge of Ambry Genetics Corporation (AG), a Konica Minolta company, and its global gene diagnostic technology, with the TOP technology, to reinforce the informatics foundation technology of the TOP and develop a breakthrough, next-generation, comprehensive gene panel test with advanced functionality. The TOP has a large number of targets of oncogenic somatic gene mutations in the DNA panel and fusion gene detection analysis in the RNA panel. AG is the world leader in germ cell mutation detection technology and was among the first to commercialize RNA testing to assess germline mutations.